# Quadrise collaborates with Cargill and MAC2 for marine vessel trials of MSAR and bioMSAR fuels

- Link: https://www.directorstalkinterviews.com/quadrise-collaborates-with-cargill-and-mac2-for-marine-vessel-trials-of-msar-and-biomsar-fuels/4121141142
- Published: 2024-02-06T07:03:00+00:00
- Author: Amilia Stone

**[Quadrise Plc](https://www.directorstalkinterviews.com/company/quadrise-plc/qed.l)**(
LON:QED), the supplier of innovative energy solutions for a cleaner planet, has 
announced the signature of a Collaboration Agreement with Cargill NV, a major supplier
of renewable biofuels, and MAC^(2) Solutions NV, part of Group Machiels, with regard
to the production of MSAR® and bioMSAR™ fuels for the Company’s forthcoming marine
vessel trials.

Under the Collaboration Agreement between the parties, the Trials will be carried
out following the installation and commissioning of Quadrise equipment at the MAC
^(2) facility in Antwerp, Belgium. Cargill will be responsible for the supply of
feedstocks, as well as for bunkering operations to supply MSAR® and bioMSAR™ fuel,
for the Trials. MAC^(2 ) will be responsible for the supply of jetty space, utilities,
permits and ad-hoc support services during the Trials, whilst Quadrise will be responsible
for the provision of MSAR® and bioMSAR™ technology and fuel production equipment
and personnel.

Further to the Company’s AGM Statement on 27 November 2023, this Collaboration Agreement
is the first of a number of agreements with stakeholders that are required in order
to supply MSAR® and bioMSAR™ to the MSC Leandra for Proof of Concept (“POC”) and
Letter of No Objection (‘LONO’) trials commencing Q2 2024.

Subject to the conclusion of the remaining required agreements, including a toll
manufacturing agreement between Cargill and Quadrise in respect of fuel manufacture,
Quadrise equipment is expected to be delivered to the MAC^(2) site to enable the
Trials to commence in Q2 this year, following the receipt of permits for the Trials
by MAC^(2). The Trials will commence with POC tests using MSAR® and bioMSAR™ followed
then by several thousand hours of operation on bioMSAR™ in order to obtain a LONO
from the original equipment manufacturer. Quadrise anticipates that the bioMSAR™
LONO trial will take approximately 6-8 months after the POC trials are completed
within around 2 months, subject to the commercial route of the MSC Leandra during
the Trials.

Upon successful LONO trial completion and entry of a long-term fuel supply agreement,
the parties plan to seek to initiate commercial MSAR® and bioMSAR™ bunker supply
operations to the marine sector by Cargill through the MAC^(2) facilities in Port
of Antwerp-Bruges on a permanent basis.

> **Commenting on the update, Jason Miles, Chief Executive Officer of Quadrise, 
> said:**
> _“We are delighted to have signed this agreement with Cargill and MAC^(2) to progress
> our plans for supplying MSAR® and bioMSAR™ to the marine sector from Antwerp-Bruges.
> We look forward to working with them as we prepare for the trials on the MSC Leandra
> in Q2 2024 and to a successful longer-term partnership as we progress to commercial
> supply.”_

Share on: